Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection
Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection
Not yet recruiting · NCT07709299 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Early phase 1 | 2026-07-16 | NCT07709299 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bahar Tashkhis Teb | 1 |
| Kian Immune Cell Company | 1 |
| Royan Institute | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Liver Transplant and Surgery Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences | Tehran | Iran | 1 |